FibroBiologics, Inc Common Stock

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$0
$0
$0
$554
Gross Profit
-231
-206
277
EBITDA
-5,547
-4,452
-4,805
-2,940
EBIT
-5,778
-4,658
-4,966
-3,093
Net Income
-5,778
-4,658
-4,966
-3,099
Net Change In Cash
0
0
0
554
Free Cash Flow
-3,978
-4,197
-5,318
-3,172
Cash
4,867
8,845
8,667
13,985
Basic Shares
43,072
38,635
36,673
34,774

Annual Financials

Values in thousands2025-06-302024-06-302023-06-302022-06-30
Revenue
$0
$0
$0
$0
Gross Profit
-573
-437
-94
EBITDA
-10,568
-15,901
-4,373
-1,578
EBIT
-11,141
-16,338
-4,467
Net Income
-11,161
-16,485
-5,121
-1,582
Net Change In Cash
0
0
0
0
Free Cash Flow
-12,085
-6,896
-4,066
-1,410
Cash
13,985
9,163
2,266
407
Basic Shares
32,875
32,492
32,477
32,477

Earnings Calls

QuarterEPS
2025-09-30
-$0.13
2025-06-30
-$0.12
2025-03-31
-$0.14
2024-12-31
-$0.09